[Chilean experience with the use of 18F-deoxyglucose positron emission tomography].

Autor:	Massardo T; Sección Medicina Nuclear, Departamento de Medicina, Hospital Clínico, Universidad de Chile, Santiago, Chile. tmassardo@redclinicauchile.cl, Jofré MJ, Sierralta P, Canessa J, González P, Humeres P, Valdebenito R
Jazyk:	Spanish; Castilian
Zdroj:	Revista medica de Chile [Rev Med Chil] 2007 Mar; Vol. 135 (3), pp. 375-83. Date of Electronic Publication: 2007 Apr 26.
DOI:	10.4067/s0034-98872007000300014
Abstrakt:	Background: Clinical oncology is the main application of 18F-deoxyglucose (FDG) positron emission tomography (PET). Aim: To evaluate the first 1,000 patients studied with FDG PET in Chile. Material and Methods: Retrospective analysis of 1,000 patients (aged between 1 and 94 years, 550 females) studied with FDG PET, since 2003. All studies were performed in a high resolution Siemens Ecat-Exact HR (+). All reports were based on the visual analysis of three plane and three-dimensional images. Results: Ninety seven percent of exams were done for oncological indications, mainly lung lesions, lymphoma, colorectal and gastroesophageal, cancer and breast tumors. Only 1% of patients had brain tumors. Non tumor neurological indications corresponded to 1.7%. Cardiac studies were only 0.3% and inflammatory process corresponded to 1%. The 5.6% corresponded to pediatric population. Six percent of patients were aged less than 18 years and in 50% of them, the indication was oncological, mainly lymphomas, brain tumors, endocrine cancers and sarcomas. The remaining 50% had a neurological indications, mainly for refractory epilepsy. Conclusions: PET FDG imaging was effective in the management of diverse diseases of children and adults.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu